Condition
Malignant Mesothelioma
Estimated Enrollment: 100
Age Group: Child, Adult, Senior
Gender: All
Study Type: Observational
Study Design Allocation: Observational Model: Case-Only|Time Perspective: Prospective
Study ID Numbers: ONC/OSS-02/2011
Study First Received: May 27, 2013
Last Updated: July 20, 2016
Estimated Primary Completion Date: December 2017
Primary Outcome Measures:
dissect the molecular mechanisms underlying the development of malignant mesothelioma|study of the effect of TAMs|investigation of molecular mechanisms linking macrophages|molecular characterization (proteome) of TAMs and tumor cells|compare in specimens from mesothelioma patients and the candidate molecular markers|Investigate the association of selected markers with Overall Survival
Sponsors and Collaborators:
Armando Santoro, MD|Istituto Clinico Humanitas
Website Link: https://ClinicalTrials.gov/show/NCT02300883
